Medicine and Dentistry
Head and Neck Squamous Cell Carcinoma
100%
Neoplasm
96%
Head and Neck Cancer
82%
Disease
76%
Neck
71%
Wart Virus
65%
Recurrent Disease
57%
Surgery
53%
Otorhinolaryngology
52%
Oropharynx Squamous Cell Carcinoma
44%
Malignant Neoplasm
41%
Robot-Assisted Surgery
41%
Radiation Therapy
38%
Squamous Cell Carcinoma
37%
Neck Dissection
36%
Gene Expression
27%
Tracheotomy
26%
Laryngeal Cancer
26%
Overall Survival
25%
Radiology
25%
Head and Neck Surgery
24%
Health Care Cost
23%
Laryngectomy
22%
COVID-19
20%
Oral Cavity
19%
Larynx
18%
Thyroid Gland
17%
Cancer
16%
Metastatic Carcinoma
16%
P16
15%
Ambulatory Surgery
15%
Oropharyngeal Cancer
15%
Brachytherapy
15%
Thyroidectomy
15%
Primary Tumor
15%
Oropharynx
15%
Larynx Squamous Cell Carcinoma
14%
Hazard Ratio
14%
Squamous Cell
14%
Urban Population
13%
Tertiary Care
13%
Symptom
13%
Hydroxyurea
13%
Radiation Oncology
13%
Hypopharynx
13%
Human Papillomavirus Type 16
13%
Adjuvant Therapy
12%
Disease Specific Survival
12%
Logistic Regression Analysis
12%
Cancer Staging
11%
Keyphrases
Head-and-neck Cancer
36%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
23%
Head-and-neck
16%
Confidence Interval
16%
Otolaryngology Research
13%
Tracheotomy
13%
ACR Appropriateness Criteria
13%
Oropharyngeal Squamous Cell Carcinoma (OPSCC)
13%
Overall Survival
8%
Otolaryngology
8%
Moesin
8%
Poor Survival
8%
Laryngeal Squamous Cell Carcinoma
8%
CpG Loci
7%
Bronx
7%
Radiation Oncology
6%
Temporal Bone Model
6%
Bone Working
6%
Benign Goiter
6%
Parotid Mass
6%
Opioid Use
6%
Faculty Evaluation
6%
Occult Nodal Disease
6%
Workforce Issues
6%
Resident Selection
6%
Recurrent Angioedema
6%
Cancer Cell Culture
6%
Compressive Symptoms
6%
Laryngeal Cancer
6%
Recurrent Metastatic
6%
CDNA Microarray
6%
Mitotic Gene
6%
LBH589
6%
Romidepsin
6%
Conditional Reprogramming
6%
Therapeutic Nanomedicine
6%
Pleomorphic Adenoma
6%
MiR-30a-5p
6%
Subcellular Expression
6%
Becaplermin
6%
Pharyngocutaneous Fistula
6%
Usage Patterns
6%
Bioinformatics
6%
Molecular Signature
6%
Late Failure
6%
Ipsilateral Radiotherapy
6%
Response to Chemoradiotherapy
6%
Obesity
6%
Pharyngeal Carcinoma
6%
Hyperfractionated
6%